Company / Operating Margin
C4 Therapeutics, Inc. Operating Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-320.5%
FY2025
5-year range
-669.8% / -179.4%
FY2022-FY2025
Trend
+52.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -669.8% to -320.5% over the past 2 years.
Based on SEC 10-K filings.
-320.5% in FY2025 with a 3-year CAGR of -141.1%.
Improved from -669.8% to -320.5% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -141.1pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 52.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -320.5% | +52.1% |
| FY2024 | -669.8% | +0.0% |
| FY2023 | -669.8% | -273.4% |
| FY2022 | -179.4% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026